Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

NCT00170911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: AAE581

Sponsor

Novartis Pharmaceuticals